Immunity to Toxoplasma gondii - into the 21st century

Parasite Immunology

Volumn 37, Issue 3, 2015, Pages 105-107

  Coombes, J L ^a   Hunter, C A ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Encephalitis; Immunology; Toxoplasma

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

CELLULAR IMMUNITY; EDITORIAL; ENCEPHALITIS; HOST CELL; HOST PARASITE INTERACTION; HUMAN; IMMUNE EVASION; NATURAL KILLER CELL; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMIC ENCEPHALITIS; TOXOPLASMOSIS; ANIMAL; IMMUNOLOGY; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY; TOXOPLASMA; VIRULENCE;

TOXOPLASMA; TOXOPLASMA GONDII;

ANIMALS; ENCEPHALITIS; HUMANS; IMMUNITY, CELLULAR; TOXOPLASMA; TOXOPLASMOSIS; VIRULENCE;

EID: 84923011657     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12177     Document Type: Editorial

References (26)

1. Wolf A, Cowen D & Paige B. Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science 1939; 89: 226-227.
2. Sabin AB & Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948; 108: 660-663.
3. Ruskin J & Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med 1976; 84: 193-199.
4. Montoya JG & Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976.
5. Remington JS & Merigan TC. Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii). Science 1968; 161: 804-806.
6. Gazzinelli RT, Hieny S, Wynn TA, Wolf S & Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993; 90: 6115-6119.
7. Dardé ML, Villena I, Pinon JM & Beguinot I. Severe toxoplasmosis caused by a Toxoplasma gondii strain with a new isoenzyme type acquired in French Guyana. J Clin Microbiol 1998; 36: 324.
8. Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992; 114: 136-144.
9. Yolken RH & Dickerson FB & Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol 2009; 31: 706-715.
10. Dubey JP, Hill DE, Rozeboom DW, et al. High prevalence and genotypes of Toxoplasma gondii isolated from organic pigs in northern USA. Vet Parasitol 2012; 188: 14-18.
11. Cohen SB & Denkers EY. The gut mucosal immune response to Toxoplasma gondii. Parasite Immunol 2014; 3: 108-117.
12. Luu L & Coombes JL. Dynamic two-photon imaging of the immune response to Toxoplasma gondii infection. Parasite Immunol 2014; 3: 118-126.
13. English ED, Adomako-Ankomah Y & Boyle JP. Secreted effectors in Toxoplasma gondii and related species: determinants of host range and pathogenesis? Parasite Immunol 2014; 3: 127-140.
14. Hunter CA & Sibley LD. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 2012; 10: 766-778.
15. Saeij J, Boyle JP, Coller S, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 2006; 314: 1780-1783.
16. Saeij J, Coller S, Boyle JP, Jerome ME, White MW & Boothroyd JC. Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature 2006; 445: 324-327.
17. Taylor S, Barragan A, Su C, et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 2006; 314: 1776-1780.
18. Reese ML, Zeiner GM, Saeij JPJ, Boothroyd JC & Boyle JP. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 2011; 108: 9625-9630.
19. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K & Sibley LD. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci USA 2011; 108: 9631-9636.
20. Koshy AA, Dietrich HK, Christian DA, et al. Toxoplasma co-opts host cells it does not invade. PLoS Pathog 2012; 8: e1002825.
21. Weidner JM & Barragan A. Tightly regulated migratory subversion of immune cells promotes the dissemination of Toxoplasma gondii. Int J Parasitol 2014; 44: 85-90.
22. Harker KS, Ueno N & Lodoen MB. Toxoplasma gondii dissemination: a parasite's Journey through the Infected Host. Parasite Immunol 2014; 3: 141-149.
23. Blanchard N, Dunay IR & Schlüter D. Persistence of Toxoplasma gondii in the central nervous system: a fine tuned balance between the parasite, the brain and the immune system. Parasite Immunol 2015; 3: 150-158.
24. Feliu V, Vasseur V, Grover HS, et al. Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite. PLoS Pathog 2013; 9: e1003449.
25. Blanchard N, Gonzalez F, Schaeffer M, et al. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat Immunol 2008; 9: 937-944.
26. Parlog A, Schlüter D & Dunay IR. Toxoplasma gondii induced neuronal alterations. Parasite Immunol 2014; 3: 159-170.